—

GlaxoSmithKline PLC ADR (GSK) — the peer cohort

As of 2026-10-13 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

GlaxoSmithKline PLC ADR ranks 10 of 11 in its cohort on the Closelooknet composite (52/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GSK GlaxoSmithKline PLC ADR 52 26 79 57 info 23%
LLY Eli Lilly and Company 64 71 91 27 bull 8.5%
ORNAV.HE Orion Oyj A 62 81 83 32 ok 2.6%
ORNBV.HE Orion Oyj B 62 82 83 32 ok 2.2%
SAN.PA Sanofi SA 56 34 68 60 watch 18.1%
NVO Novo Nordisk A/S 55 23 86 74 bear 37.7%
GRF.MC Grifols S.A. 49 53 42 78 info 17.7%
HALO Halozyme Therapeutics Inc 74 93 94 48 ok 6.2%
DXCM DexCom Inc 66 85 80 35 bull 7.2%
ONC BeiGene, Ltd. 63 75 62 30 info 9.4%
MEDP Medpace Holdings Inc 63 83 74 28 ok 10%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-13

Quick answers

Who are GlaxoSmithKline PLC ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Sanofi SA (SAN.PA), Novo Nordisk A/S (NVO), Grifols S.A. (GRF.MC), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM) and others.

How does GSK score against its peers?

GlaxoSmithKline PLC ADR's composite reads 52/100, ranking 10 of 11 in its cohort as of 2026-10-13; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.